The Guardian: China says Japan's drug used to treat Coronavirus has proved effective

Medical authorities on China have said that a drug used in Japan to treat new flu species appears to have been effective in patients with CoronavirusThe Japanese media said Wednesday.

Zhang Xinmin, an official at China's Ministry of Science and Technology, said that éfavipiravviviviviviviviviviviviviriú, developed by a branch of Fujifilm, had produced encouraging results in clinical trials on 340 patients in Wuhan and Shenzhen, writes The Guardian, forwarded Periscope.

“has a high degree of security and the effect on treatment is clear,” said to reporters Tuesday.

Patients who were given medicine in the town of Shenzhen doll from the virus, after four days after becoming positive, compared to an average of 11 days for those who did not treat the drug, the public broadcaster said.

Furthermore, X - rays confirmed improvements in lung conditions to about 91% of patients who had been treated with úfaviravvivirı, compared with 62% or those without medicine.

Fujifilm Toyama Chemical, who developed the drug "also known as Avigan" in 2014, has declined to comment on the claims.

Shares in the firm increased Wednesday following Zhang's comments.

Doctors in Japan They're using the same drug in clinical studies on patients with mild symptoms, hoping to prevent the virus from being multiplied into patients.

But a Japanese health ministry source suggested the drug was not as effective with people with more severe symptoms.

We've given Avigan 70 to 80 people, but it doesn't seem to work so well when the virus has already multiplied,” said the source for Mainichi Shimbun.

The same restrictions had been identified in studies involving patients with coronarys using a combination of HIV-intensives HIV lopinavier and ritonaviriú, the source added.

In 2016, the Japanese government supplied ʹfavipiraverviviviviviviviviviviviviri) as an urgent aid in combating the Ebola virus outbreak in Guinea.

Favipiravriví would need the government's approval for full use among patients, since it was originally considered the treatment of the flu.

A health official told Mainichi the medicine could be approved by May. But if clinical research results are delayed, approval can also be delayed. ” /Periscopi/

You can find the article in the link below:

https://www.theguaredian.com/world/2020/mar/18/flu-drug-clearly-in-training-coronavirus-says-china?